Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Norah O Abanmy"'
Publikováno v:
PLoS ONE, Vol 13, Iss 6, p e0199208 (2018)
Dasatinib (DAS) is a tyrosine kinase inhibitor (TKI) used in the treatment of chronic myeloid leukemia and in the management of ulcerative colitis (UC). Since some nutraceuticals (e.g. curcumin, olive oil, and cocoa extract) could alter the function
Externí odkaz:
https://doaj.org/article/4b6a74901e224aeb9193a88e12323b03
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
BackgroundLaws and regulations are needed to regulate the growing online pharmacy (OP) services. The main objective of this work was to provide an overview of the laws and regulations for OP services in the Gulf Cooperation Council (GCC) countries. I
Externí odkaz:
https://doaj.org/article/3b8404ed452a4bb997c3d28f7554f3f5
Publikováno v:
Saudi Pharmaceutical Journal, Vol 32, Iss 4, Pp 102022- (2024)
Background: Single nucleotide polymorphisms in the gene encoding proteins involved in mercaptopurine metabolism can influence drug efficacy and safety. This study aims to assess clinical pharmacists’ knowledge about mercaptopurine-related genes and
Externí odkaz:
https://doaj.org/article/861252181804472da19c2aabd835a132
Autor:
Jawza F. Alsabhan, Haya M. Almalag, Norah O. Abanmy, Yara I. Aljadeed, Reema H. Alhassan, Awatif B. Albaker
Publikováno v:
Saudi Pharmaceutical Journal, Vol 32, Iss 4, Pp 101997- (2024)
Background: The goal of this study was to identify and evaluate the use of Arabic YouTube videos on BD as a resource for patient education. Methods: A cross-sectional evaluation of YouTube videos as a source of information for patients with BD in Ara
Externí odkaz:
https://doaj.org/article/00d7f2ff07d74a1a9fd1e29a6d606c82
Autor:
Omar A. Almohammed, Rawan A. Alnogaidan, Fatmah O. Ghannam, Reem S. Alqahtani, Shoug K. Aloraini, Norah O. Abanmy
Publikováno v:
Saudi Pharmaceutical Journal, Vol 31, Iss 8, Pp 101676- (2023)
Purpose: Online pharmacies (OPs) represent a growing field that plays a major role in providing pharmaceutical services in Saudi Arabia (SA). Thus, investigating public awareness of this option and assessing consumers’ experiences and satisfaction,
Externí odkaz:
https://doaj.org/article/152b4bb1132e46559d093e4d20116e58
Publikováno v:
Saudi Pharmaceutical Journal, Vol 29, Iss 12, Pp 1392-1398 (2021)
Saudi Pharmaceutical Journal : SPJ
Saudi Pharmaceutical Journal : SPJ
Brain derived neutrophic factor (BDNF) is a protein and a member of the neurotrophin family of growth factors, supports the survival of existing neurons and encourages the growth and differentiation of new neurons and synapses. The BDNF gene Val66Met
Publikováno v:
Saudi Pharmaceutical Journal, Vol 27, Iss 6, Pp 841-845 (2019)
Saudi Pharmaceutical Journal : SPJ
Saudi Pharmaceutical Journal : SPJ
Background: Deiodinases comprise a group of selenoproteins that regulate the bioavailability of active thyroid hormones (TH) in a time and tissue specific fashion. They increase the hormonal activity by metabolizing their inactive precursors to activ
Autor:
Albatool A. Bin Ajlan, Gamal A. Shazly, Rawan A. Almugbel, Maha Al-Rasheed, Lina Hammad, Shaikha Y. Aldukhail, Alaa A. Assiri, Abeer F. Altaweel, Norah O. Abanmy
Publikováno v:
Journal of advanced Biomedical and Pharmaceutical Sciences.
Background/Aims: Maintaining skin elasticity and hardness is one way of keeping younger skin. This study investigates the topical effects of Aloe Vera (AV) alone and accompanied with Omega-3 (O-3) on skin hardness and thickness. Method: Healthy femal
Autor:
Norah O. Abanmy
Publikováno v:
Saudi Pharmaceutical Journal, Vol 25, Iss 6, Pp 891-899 (2017)
Purpose Online pharmacies sell medicine over the Internet and deliver them by mail. The main objective of this study is to explore the extent of use of online pharmacies in Saudi Arabia which will be useful for the scientific community and regulators
Publikováno v:
Biomedical chromatography : BMCREFERENCES. 33(12)
Tyrosine kinase inhibitor treatments for chronic myeloid leukaemia based on nilotinib (NIL), dasatinib (DAS) and imatinib (IMA) have improved patient quality of life and have turned chronic myeloid leukemia from a fatal disease into a chronic disease